LIVE TV
LIVE TV
LIVE TV
Home > Business News > AbbVie trims 2026 profit forecast on Apogee buy, beats second-quarter estimates

AbbVie trims 2026 profit forecast on Apogee buy, beats second-quarter estimates

Written By:
Published: July 31, 2026 17:26:10 IST

Add NewsX As A Trusted Source

July 31 (Reuters) – AbbVie trimmed its 2026 profit forecast on Friday to account for its planned Apogee Therapeutics acquisition, while topping second-quarter estimates on strong immunology drug sales

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

LATEST NEWS